Association between Plasminogen Activator Inhibitor-1 and Osimertinib Tolerance in EGFR-Mutated Lung Cancer via Epithelial–Mesenchymal TransitionKentaro Tokumo, Noboru Hattori|Cancers|2023Cited by 9